HOME >> BIOLOGY >> NEWS
Progress being made in exploring potential use of stem cells to treat heart disease

Scientists are making headway in exploring the potential future use of stem cells to treat heart disease, according to a review article in the current issue of Nature (June 29, 2006).

Authored by Gladstone Institute of Cardiovascular Disease Director Deepak Srivastava, MD, and Gladstone Institutes postdoctoral scholar Kathryn Ivey, PhD, the paper cites a better understanding of the following areas of research:

  • the developmental processes within the heart that can be reproduced using pluripotent embryonic stem cells (these are early stem cells that can grow into almost any cell type)
  • the cues that control multipotent cardiac stem cells (these stem cells, which have less developmental potential than embryonic stem cells, produce different types of cells that make up the heart)
  • the ability of circulating progenitor cells (early-stage cells that have not yet differentiated, or specialized) to produce factors that are sufficient to invoke cell survival or repair responses in damaged heart cells

"The use of stem cells to generate replacement cells for damaged heart muscle, valves, vessels and conduction cells holds great potential," says Srivastava, who is also a UCSF professor of pediatrics and the Wilma and Adeline Pirag Distinguished Professor in Pediatric Developmental Cardiology. "Although there are clearly many obstacles to overcome, it is significant that a roadmap of the derivation and use of stem cells for human heart disease is now conceivable."

In the Nature article, Srivastava and Ivey point to several challenges ahead:

  • Developing the ability not only to guide and expand stem cells into the cardiac lineage but also to repress alternative cell fates
  • Developing methods for safe delivery and proper integration of stem cells within patients' heart tissue to avoid such complications as arrhythmias (irregular heart beat)
  • Solving immunological issue
    '"/>


Contact: John Watson
jwatson@gladstone.ucsf.edu
415-734-2019
Gladstone Institutes
28-Jun-2006


Page: 1 2

Related biology news :

1. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
2. Progress toward a targeted therapy for a specific form of leukemia
3. Progress against sarcoma
4. Progress toward artificial photosynthesis?
5. 2nd annual Albert Szent-Gyrgyi Prize for Progress in Cancer Research awarded to Webster K. Cavenee
6. Progress in battle against life-threatening acute allergy
7. Progress report on Homogeneous Assay project
8. Media Invite: Dinner to award prize for Progress in Cancer Research
9. Progress needed on global regime for access to genetic resources and benefit-sharing
10. Albert Szent-Gyrgyi Prize for Progress in Cancer Research announced
11. Progress toward a new remedy for chronic urinary tract infections?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... ... September 21, 2018 , ... VTE can ... untreated, can lead to significant morbidity and mortality. VTE affects between 300-600,000 Americans ... autopsy. Further, PE is the leading cause of preventable hospital death and maternal ...
(Date:9/12/2018)... ... September 11, 2018 , ... Tennant ... introduce the new ChemXP™ line of high performance secondary containment coatings, designed to ... to provide Tennant Coatings’ elite certified installers with the needed solutions to protect ...
(Date:9/7/2018)... ... September 06, 2018 , ... Sensors Midwest ... show Sensors Expo & Conference , announces their partnership with Fraunhofer USA ... an IoT Enabled Industrial IoT Certification Program. Taking place on October 17, 2018 ...
Breaking Biology News(10 mins):
(Date:9/13/2018)... ... September 13, 2018 , ... Asymmetrex’s director, James L. ... have gotten in medicine, if we didn’t have the means to measure the number ... His answer, “Nowhere! And that is what’s holding up progress in stem cell ...
(Date:9/12/2018)... ... 11, 2018 , ... Sterlitech Corporation, a global leader in ... from Fluid Technology Solutions (FTS H2O) to their offering of filtration products. ... triacetate (CTA) material. The highly hydrophilic nature of the CTA FO membranes favors ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... September 25th-28th is a meeting of “The industry’s preeminent event on novel drug ... discovery scientists powerful tools to study these emerging targets in a quest to ...
(Date:9/7/2018)... , ... September 06, 2018 , ... Akadeum Life Sciences ... spent his career as an executive and leader of numerous biotech companies. , ... therapy and biologics company acquired by Thompson Street Capital in St. Louis, MO. ...
Breaking Biology Technology:
Cached News: